David E. Wheadon - 16 Jun 2021 Form 4 Insider Report for Vaxart, Inc. (VXRT)

Role
Director
Signature
/s/ Margaret Echerd, Attorney-in-Fact for David Wheadon
Issuer symbol
VXRT
Transactions as of
16 Jun 2021
Net transactions value
$0
Form type
4
Filing time
17 Jun 2021, 19:29:43 UTC
Previous filing
01 Jun 2021
Next filing
31 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VXRT Stock Option (right to buy) Award $0 +65,700 $0.000000 65,700 16 Jun 2021 Common stock 65,700 $6.54 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted by the board of directors of Vaxart, Inc. effective on May 10, 2021, subject to stockholder approval of an amendment to the Vaxart, Inc. 2019 Equity Incentive Plan, under which the stock option was granted. Vaxart, Inc.'s stockholders approved the plan amendment on June 16, 2021.
F2 The shares subject to this option shall vest annually over three years from the vesting commencement date of April 21, 2021, the date of the grantee's appointment as a director of Vaxart, Inc.